<<

Drugs with ACB Score of 1 Drugs with ACB Score of 2 Drugs with ACB Score of 3 Generic Name Brand Name Generic Name Brand Name Generic Name Brand Name Theralen™ Symmetrel™ Elavil™ Spasmonal™ Belladonna Multiple Asendin™ Alprazolam Xanax™ Tegretol™ Sal- Abilify™ Flexeril™ Benztropine Cogentin™ Dimetapp™ Saphris™ Periactin™ Atenolol Tenormin™ Histex™, Carbihist™ Loxitane™ Wellbutrin™, Zyban™ Chlorpheniramine Chlor-Trimeton™ Meperidine Demerol™ Captopril Capoten™ Thorazine™ Methotrimeprazine Levoprome™ Zyrtec™ Tavist™ Chlorthalidone Diuril™, Hygroton™ Molindone Moban™ Anafranil™ Tagamet™ Nefogesic™ Clozaril™ Clidinium Librax™ Trileptal™ Enablex™ Clorazepate Tranxene™ Orap™ Norpramin™ Codeine Contin™ Dicyclomine Bentyl™ Colchicine Colcrys™ Dramamine™, others Clarinex™ Categorical Scoring: Benadryl™, others Diazepam Valium™ • Possible include those listed with a Sinequan™ Digoxin Lanoxin™ score of 1; Definite anticholinergics include those Unisom™, others Dipyridamole Persantine™ listed with a score of 2 or 3 Toviaz™ Disopyramide Norpace™ Urispas™ Fentanyl Duragesic™, Actiq™ Numerical Scoring: Atarax™, Vistaril™ Furosemide Lasix™ • Add the score contributed to each selected Anaspaz™, Levsin™ Fluvoxamine Luvox™ in each scoring category Tofranil™ Haldol™ • Add the number of possible or definite Antivert™ Hydralazine Apresoline™ Methocarbamol Robaxin™ Hydrocortisone Cortef™, Cortaid™ Pamelor™ Fanapt™ Zyprexa™ Isosorbide Isordil™, Ismo™ Norflex™ Notes: Xyzal™ Ditropan™ Loperamide Immodium™, others • Each definite anticholinergic may increase the risk of Paxil™ 3 Claritin™ cognitive impairment by 46% over 6 years. Trilafon™ Metoprolol Lopressor™, Toprol™ • For each on point increase in the ACB total score, a Phenergan™ MS Contin™, Avinza™ decline in MMSE score of 0.33 points over 2 years has Propantheline Pro-Banthine™ 4 Procardia™, Adalat™ been suggested. Detrunorm™ Invega™ • Additionally, each one point increase in the ACB total Seroquel™ Prednisone Deltasone™, Sterapred™ score has been correlated with a 26% increase in the Transderm Scop™ Quinaglute™ risk of death. 4 Vesicare™ Zantac™ Mellaril™ Risperdal™ Detrol™ Theophylline Theodur™, Uniphyl™ Stelazine™ Desyrel™ Artane™ Dyrenium™ Aging Brain Care Surmontil™ Venlafaxine Effexor™ Trospium Sanctura™ Warfarin Coumadin™ www.agingbraincare.org Medications Reviewed in 2012 Update Complete References: Aging Brain Care Medications Added with Medications Added with 1. Boustani MA, Campbell NL, Munger S, Maidment I, Fox Score of 1: Score of 2: GC. Impact of anticholinergics on the aging brain: a review Aripiprazole (Abilify™) Nefopam (Nefogesic™) and practical application. Aging Heatlh. 2008;4(3):311-320. Asenapine (Saphris™) ANTICHOLINERGIC Cetirizine (Zyrtec™) Medications Added with 2. Campbell N, Boustani M, Limbil T, et al. The cognitive Clidinium (Librax™) Score of 3: impact of anticholinergics: a clinical review. Clinical Interventions in Aging. 2009;4(1):225-233. COGNITIVE BURDEN Desloratadine (Clarinex™) Doxylamine (Unisom™, Iloperidone (Fanapt™) others) 3. Campbell N, Boustani M, Lane K, et al. Use of anticholinergics SCALE Levocetirizine (Xyzal™) Fesoterodine (Toviaz™) and the risk of cognitive impairment in an African- Loratadine (Claritin™) Propiverine (Detrunorm™) American population. Neurology. 2010;75:152-159. Paliperidone (Invega™) Solifenacin (Vesicare™) Venlafaxine (Effexor™) Trospium (Sanctura™) 4. Fox C, Richardson K, Maidment I, et al. Anticholinergic medication use and cognitive impairment in the older population: the Medical Research Council Medications Reviewed But NOT Added: Cognitive Function and Ageing Study. Journal of the American Geriatric Society. 2011; 59(8): 1477-1483. (Allegra™) 2012 Update (Neurontin™) 5. Cai X, Campbell N, Khan B, Callahan C, Boustani M. (Topamax™) Long-term anticholinergic use and the aging brain. Levetiracetam (Keppra™) Alzheimers Dementia. 2012; epub ahead of print. Developed by the Aging Brain Program Tamoxifen (Nolvadex™) of the Indiana University Center for (Axid™) Aging Research Duloxetine (Cymbalta™)

Criteria for Categorization: Score of 1: Evidence from in vitro data that chemical entity has antagonist activity at muscarinic receptor. Copyright © 2008, 2012. Regenstrief Institute, Inc. All rights reserved.

Score of 2: Evidence from literature, prescriber’s Use of the Anti- Burden (ACB) Scale may only be information, or expert opinion of clinical anticholinergic in accordance with the Terms of Use for the ACB Scale which effect. are available at http://www.agingbraincare.org/tools/abc- anticholinergic-cognitive-burden-scale. Score of 3: Evidence from literature, expert opinion, To request permission for use, contact us at or prescribers information that medication may cause [email protected]. delirium.